Precision Recruitment in Alzheimer’s Trials

Wholly Owned Sites Built for Complex, Biomarker-Driven Studies

Talk To Our Experts About Your Trial

The Right Alzheimer's Site Network for Your Trials

As the Alzheimer’s drug development landscape increases in complexity, the challenges increase right along with it.

  • Growing study competition
  • Potential recruitment bottlenecks from biomarker requirements
  • Rising complexity from next-generation and combination therapies
  • Increasing demand for diverse, representative trial populations

Flourish Research is built to overcome these challenges, with experienced Alzheimer’s investigators, biomarker-informed recruitment, dedicated PET imaging, CSF and APOE testing capabilities, and access to diverse patient populations across a wholly owned U.S. site network.

Proven Ability to Conduct Complex Alzheimer's Studies

Flourish Research has Alzheimer’s experience spanning mild cognitive impairment to later stage Alzheimer’s disease and dementia.

  • Disease-modifying therapies, prevention, and imaging-based study experience
  • Access to diverse patient populations
  • Expertise in immunomodulation and anti-tau/anti-amyloid therapies
200 Phase I-IV Alzheimer's and dementia trials

Biomarker Experience

Our sites have experience overcoming operational challenges in complex biomarker driven Alzheimer’s studies.

  • Blood-based biomarkers, including amyloid and pTau217
  • Onsite lumbar puncture and CSF assay capabilities
  • APOE genetic testing experience
  • Prescreened patient databases

Imaging Onsite

In addition to MRI and PET imaging partnerships across our network, our Gainesville, GA site features a dedicated PET imaging facility. This owned imaging capability eliminates contracting and scheduling barriers, helping accelerate study startup and patient screening for your studies.

  • GE HealthCare Omni™ PET scanner
  • Dedicated onsite support for imaging-driven trial endpoints
  • Ability to conduct Alzheimer’s and oncology tracer studies onsite

Meet Some of Our Alzheimer's-experienced Principal Investigators

Mohammad R. Bolouri MD

Principal Investigator – Charlotte, NC

Jeffrey Ross MD

Principal Investigator, Flourish – Chicago

David Kirk DO

Principal Investigator – Merritt Island, FL

Planning an Alzheimer’s or dementia trial?

Connect with Flourish Research to discuss protocol fit, site capabilities, recruitment strategy, and biomarker-driven screening support across our clinical site network.

Name(Required)
Email(Required)
Please let us know any details about your study that would be helpful in getting you connected with the right experts.

Flourish Research News

Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.